Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5464264 | 0.87 | MPI (0.56) | MPITDP1KDM4EMEN1MAPT | |
| SCHEMBL9333589 | 0.81 | MPI (0.46) | MPITDP1 | |
| SCHEMBL6091772 | 0.78 | MPI (0.49) | MPITDP1 | |
| SCHEMBL4602685 | 0.78 | TDP1 (0.45) | MPITDP1KDM4EMEN1MAPT | |
| SCHEMBL4603835 | 0.77 | KMT2A (0.53) | MPITDP1KDM4EMEN1MAPT | |
| SCHEMBL10670882 | 0.74 | TSHR (0.38) | MPITDP1MEN1HTTKMT2A | |
| SCHEMBL4602669 | 0.73 | MPI (0.38) | MPITDP1KDM4EMEN1MAPT | |
| SCHEMBL6660643 | 0.73 | MAPT (0.42) | TDP1KDM4EMEN1MAPTHTT | |
| SCHEMBL4613468 | 0.73 | MPI (0.44) | MPITDP1KDM4EMAPTHTT | |
| SCHEMBL9750449 | 0.73 | MAPT (0.40) | MPITDP1MEN1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470471-B1 | METHINE DYES | LANXESS DEUTSCHLAND GMBH (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-113943493-A | Method for synthesizing spirooxazine photochromic dye by using microchannel reactor | 广州盛色科技有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-7132550-B2 | Process for the preparation of cyanine dyes with polysulfonate anions | EASTMAN KODAK COMPANY (US) | 2006-11-07 | — | — | US | disclosed |
| EP-1535968-A2 | Process for the preparation of cyanine dyes with polysulfonate anions | Kodak Polychrome Graphics, LLC (US) | 2005-06-01 | — | — | EP | disclosed |
| US-20050113546-A1 | Process for the preparation of cyanine dyes with polysulfonate anions | KODAK REALTY INC. | 2005-05-26 | — | — | US | disclosed |
| EP-0339661-B1 | Photochromic substances | RODENSTOCK OPTIK G (DE) | 1994-04-20 | — | — | EP | disclosed |
| EP-0339661-A2 | Photochromic substances | Optische Werke G. Rodenstock (DE) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113546-A1 | Process for the preparation of cyanine dyes with polysulfonate anions | MPST, ALG3, KIT | MPI 1735/4885TDP1 4222/4885KDM4E 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.